Hepatotoxicity after a short course of low-dose pyrazinamide

Acta Gastro-Enterologica Belgica

Volumn 59, Issue 4, 1996, Pages 251-253

  Al Sarraf, K A A ^a,d   Michielsen, P P ^a,e   Hauben, E I ^a   Lefebure, A ^b   Ramon, A M ^a,c   Van Marck, E A ^a   Pelckmans, P A ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Stuivenberg General Hospital   (Belgium)

^c Intl Institute of Immunopathology   (Germany)

^d RASHID HOSPITAL   (United Arab Emirates)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

hepatotoxicity; pyrazinamide; tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL TRIAL; HEPATITIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER NECROSIS; LIVER TOXICITY; LUNG TUBERCULOSIS; MALE;

ADULT; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS, TOXIC; HUMANS; LIVER; MALE; PYRAZINAMIDE; RIFAMPIN;

EID: 0030432524     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. YEAGER R.L., MUNROE W.G.C., DESSAU F.I. Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis. Am. Rev. Tuberc., 1952, 65 : 523-546.
2. MC DERMOTT W., ORMOND L, MUSCHENHEIM C., DEUSCHLE K., MC CUNE R.M.Jr, TOMPSETT R. Pyrazinamide-isoniazid in tuberculosis. Am. Rev Tuberc., 1954, 69 : 319-333.
3. American Thoracic Society - Medical Section of the American Lung Association. Treatment of tuberculosis infection in adults and children. Am. Rev. Respir. Dis., 1986, 134 : 355-363.
4. DANAN G., PESSAYRE D., LARREY D., BENHAMOU J.P. Pyrazinamide fulminant hepatitis : an old hepatotoxin strikes again. Lancet 1981, 2: 1056-1057.
5. DURAND F., BERNUAU J., PESSAYRE D., SAMUEL D., BELAICHE J., DEGOTT C., BISMUTH H., BELGHITI J., ERLINGER S., RUEFF B , BENHAMOU J.-P Deleterious influence of pyrazmamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology. 1995, 21 : 929-932.
6. COHEN C D., SAVED A.R, KIRSCH R.E. Hepatic complications of antituberculosis therapy revisited. S. A. Med. J., 1983, 63 : 960-963.
7. O'BRIEN R.J. Hepatotoxic reaction to antituberculous drugs : adjustments to therapeutic regimen. J. Am. Med. Ass., 1991, 265 : 3323.
8. STEELE, M.A., BURK R.F., DESPREZ R.M. Toxic hepatitis with isoniazid and rifampicin : a meta-analysis. Chest, 1991, 99 : 465-471
9. PRETET S., FAJAC I. Le pyrazinarmide (Pirilène). Regain d'intér̄t pour cet antituberculeux. Rev Prat. Méd. Gén., 1994, 8. 17-21.
10. GRILING D.J. Adverse effects of antituberculosis drugs. Drugs, 1982, 23 : 56-74.
11. RODEN S., LAGNEAU M., HOMASSON J.P. Hépatite fulminante au pyrazmamide. Rev. Prieumol. Clin., 1990, 46 : 43.
12. FARRELL G C. Drug-induced acute hepatitis. In FARRELL G.C. (ed). Drug-induced liver disease. Churchill Livingstone, Edinburgh, 1994, 247-299.
13. DANAN G , HOMBERG J.-C. BERNUAU J., ROCHE-SCIOT J., PESSAYRE D. Hépatite à l'iproniazide. Intérêt diagnostique d'un nouvel anticorps antimitochondrial, l'anti-M6 Gastroenterol. Clin. Biol., 1983, 7 : 529-532.
14. HOMBERG J.-C., ABUAF N., HELMY-KHALIL S., BIOUR M., POUPON R., ISLAM S., DARNIS F., LEVY G , OPOLON P., BEAUGRAND M., TOULET J., DANAN G., BENHAMOU J.-P. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology, 1985, 5 : 722-727.
15. VAN DER KOOI K., MOTTET J.J., REGAMEY C. Isoniazid is not always the cause of hepatitis during treatment of tuberculosis Clin. Inf. Dis., 1994, 19 : 987-988.
16. CORBELLA X, VADILLO M., CABELLOS C., FERNANDEZ-VILADRICH P., RUFI G. Hypersensitivity hepatitis due to pyrazinamide. Scand. J. Infect. Dis., 1995, 27 : 93-94.